Fujikura
5803
Nippon Telegraph & Telephone
9432
Remixpoint
3825
4
Rakuten Group
4755
5
Toyota Motor
7203
JP Stock MarketDetailed Quotes
4583 Chiome Bioscience
- 211
- -42-16.60%
20min DelayNot Open Feb 14 15:30 JST
14.13BMarket Cap-8.57P/E (Static)
233High204Low11.43MVolume225Open253Pre Close2.48BTurnover30452wk High19.08%Turnover Ratio66.97MShares7552wk Low-21.13EPS TTM12.64BFloat Cap5320Historical HighLossP/E (Static)59.90MShs Float75Historical Low-24.62EPS LYR11.46%Amplitude--Dividend TTM13.28P/B100Lot Size--Div YieldTTM
Chiome Bioscience News
Chiome Bioscience: Notice regarding changes in representative directors
Chiome Bioscience: Notice Concerning Proposals (Partial Changes to the Articles of Incorporation, etc.) at the 21st Annual General Meeting of Shareholders
Chiome Bioscience: Financial results supplementary materials for the fiscal year ending 2024/12
Chiome Bioscience: Summary of financial results for the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)
Chiome Bioscience: Supplementary Information for Financial Results FY12/24
Chiome Bioscience: Non-Consolidated Financial Results (Japanese GAAP) for the Fiscal Year Ended December 31, 2024
Chiome Bioscience: Notice regarding the recording of non-operating income (subsidy income)
Chiome Bioscience: Announcement of Paper Publication on Cancer Immunotherapy Using Tribody Technology
Chiome Bioscience: Notice of publication of a paper on cancer immunotherapy using Tribody technology
Chiome Bioscience: Notice regarding completion of the exercise of the 22nd Stock Acquisition Rights (fixed exercise price type)
Chiome Bioscience: Announcement of Paper Publication on the First Part of the CBA-1205 Phase I Clinical Study
Chiome Bioscience: Notice of publication of a paper on the first half of the CBA-1205 clinical phase 1 trial
Chiome Bioscience: Announcement of research results using our antibodies in the PepTalk 24th Annual
Chiome Bioscience: Notice regarding patent assessment in Japan relating to PCDC, a candidate antibody for cancer treatment
Chiome Bioscience: Announcement of Paper Publication on CBA-1205 Non-Clinical Data
Chiome Bioscience: Notice of publication of a paper on CBA-1205 non-clinical data
Chiome Bioscience: Extension of the Master Services Agreement with Chugai Pharmaceutical Co., Ltd.
Chiome Bioscience: Notice of extension of contract period of basic contract agreement for contract research transactions with Chugai Pharmaceutical Co., Ltd.
Chiome Bioscience: Notice regarding the monthly exercise status of the 21st Stock Acquisition Rights (with exercise price amendment clause) and completion of exercise of rights
Chiome Bioscience: Notice Concerning Mass Exercise of the 21st Stock Acquisition Rights (with Exercise Price Amendment Clauses)